C.V. Starr & Co Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPDR Gold Trust
GLD
|
+$53.7M |
| 2 |
iShares Core MSCI International Developed Markets ETF
IDEV
|
+$27.4M |
| 3 |
Vanguard S&P Mid-Cap 400 ETF
IVOO
|
+$22.6M |
| 4 |
iShares Core S&P Small-Cap ETF
IJR
|
+$20.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$26.2M |
| 2 |
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
|
+$22.5M |
| 3 |
Vanguard Morningstar Small-Cap ETF
VB
|
+$20.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 99.22% |
| 2 | Healthcare | 0.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
SPDR Gold Trust
GLD
$147B
| $116M | 60.46% |
381,723
+177,230
| +87% | +$53.7M |
|
|
2
iShares Core MSCI International Developed Markets ETF
IDEV
$32.5B
| $28.8M | 14.97% |
+378,787
| New | +$27.4M |
|
|
3
Vanguard S&P Mid-Cap 400 ETF
IVOO
$3.8B
| $23.9M | 12.41% |
+227,427
| New | +$22.6M |
|
|
4
iShares Core S&P Small-Cap ETF
IJR
$107B
| $21.9M | 11.38% |
+200,458
| New | +$20.7M |
|
5
Celularity
CELU
$40.8M
| $1.5M | 0.78% |
764,069
| – | – |
|
|
6
iShares Core MSCI EAFE ETF
IEFA
$194B
| – | – |
-345,704
| Closed | -$26.2M |
|
|
7
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.1B
| – | – |
-42,100
| Closed | -$22.5M |
|
|
8
Vanguard Morningstar Small-Cap ETF
VB
$79.2B
| – | – |
-94,357
| Closed | -$20.9M |
|
Similar funds
C.V. Starr & Co's Q2 2025 Portfolio in Review
As of Q2 2025, C.V. Starr & Co held 8 positions worth $192M, up 48% from $130M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
C.V. Starr & Co deployed $54.8M of net new capital in Q2 2025, opening 3 new positions and adding to 1 existing holding. Its largest new stake was iShares Core MSCI International Developed Markets ETF: 378,787 shares worth $28.8M.
By sector, the portfolio is most concentrated in Miscellaneous at 99% of assets, up from 99% a quarter earlier, followed by Healthcare.
On the sell side, the most notable exit was iShares Core MSCI EAFE ETF, an estimated $26.2M sold.
- C.V. Starr & Co's largest Q2 2025 buy was iShares Core MSCI International Developed Markets ETF: 378,787 shares worth $28.8M.
- C.V. Starr & Co added most to SPDR Gold Trust in Q2 2025, an estimated $53.7M increase.
- C.V. Starr & Co fully exited iShares Core MSCI EAFE ETF in Q2 2025, selling an estimated $26.2M.
- C.V. Starr & Co's ten largest holdings make up 100% of its $192M portfolio in Q2 2025.
- C.V. Starr & Co opened 3 new positions and closed 3 in Q2 2025.
- C.V. Starr & Co's portfolio value rose 48% quarter-over-quarter to $192M.
Based on C.V. Starr & Co's 13F filing for Q2 2025, filed 8 Aug 2025.